Zobrazeno 1 - 10
of 8 408
pro vyhledávání: '"leptomeningeal"'
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 2541-2552 (2024)
Wenjing Zhang,1,2,* Xiaoyang Ma,1,2,* Kaiyu Qin,1,2 Cheng Kou,1,2 Canglin Song,1,2 Dongmei Xu1,2 1National Center for Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, People’s Republic of China; 2Department of
Externí odkaz:
https://doaj.org/article/33a1e5dab9e14256ab5e1656d02c4d4e
Autor:
Jia-Li Zhao, Bi-Lin Lin, Chen Luo, Yan-ling Yi, Peng Huang, Yu Chen, Sha Zhao, Zhen-Jie Huang, Xin-Yi Ma, Long Huang
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-18 (2024)
Abstract Meningeal metastasis (LM) is commonly seen in the advanced stages of cancer patients, often leading to a rapid decline in survival time and quality of life. Currently, there is still a lack of standardized treatments. Oncolytic viruses (OVs)
Externí odkaz:
https://doaj.org/article/a06117a226bc490cb9eae1fb3b6ced8f
Publikováno v:
Drug Delivery, Vol 31, Iss 1 (2024)
Leptomeningeal disease (LMD) refers to the infiltration of cancer cells into the leptomeningeal compartment. Leptomeninges are the two membranous layers, called the arachnoid membrane and pia mater. The diffuse nature of LMD poses a challenge to its
Externí odkaz:
https://doaj.org/article/ace05960f5e4499f8f88ef50f5828ede
Autor:
Yutaka Fujiwara, Katsuhiro Masago, Reiko Matsuzawa, Teppei Yamaguchi, Naohiro Watanabe, Junichi Shimizu, Eiichi Sasaki, Yoshitsugu Horio
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 942-949 (2024)
Introduction: Patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) are at increased risk of central nervous system (CNS) metastasis at initial diagnosis and throughout treatment. In a phase 3 trial, lorlatinib,
Externí odkaz:
https://doaj.org/article/2aba73a40393419a80bec87fda815105
Autor:
J. Steininger, C. Buszello, R. Oertel, M. Meinhardt, S. Schmid, K. Engellandt, S. Herold, S. Stasik, A. Ebrahimi, B. Renner, C. Thiede, I.Y. Eyüpoglu, G. Schackert, S. Beissert, F. Meier, J. Radke, D. Westphal, T. A. Juratli
Publikováno v:
Acta Neuropathologica Communications, Vol 12, Iss 1, Pp 1-12 (2024)
Abstract Epithelioid glioblastoma (eGB), a very aggressive and rare brain tumour, is associated with a dismal median overall survival. Effective therapies for patients with eGB, particularly with leptomeningeal dissemination, are still lacking. Here,
Externí odkaz:
https://doaj.org/article/0fb644eeacee4ed68b3f90f56d2e1371
Autor:
Nozomi Satani, MD, Tomonori Matsuura, MD, Satoru Yanagaki, MD, Yojiro Ishikawa, MD, Gou Watanabe, MD, Hiroshi Fukuda, MD, Takayuki Yamada, MD
Publikováno v:
Radiology Case Reports, Vol 19, Iss 8, Pp 3066-3069 (2024)
A female patient in her early 50s with breast cancer underwent breast-conserving surgery, followed by radiation therapy. She developed multiple lung and bone metastases and was started on chemotherapy with bevacizumab and paclitaxel 3 years later. Af
Externí odkaz:
https://doaj.org/article/940f2a34bbb141ba9ec2b3f8484026a4
Publikováno v:
Journal of Otology, Vol 19, Iss 3, Pp 144-147 (2024)
Objective: To report a rare case of otogenic tension pneumocephalus as a complication of a diffuse leptomeningeal glioneuronal tumor in a patient with a ventriculoperitoneal (V. P.) shunt. Patients: Twenty-three- year-old man with a confirmed diffuse
Externí odkaz:
https://doaj.org/article/d2b5ac2ca03e4be890877852e0dc4e38
Autor:
V. S. Khalilov, A. N. Kislyakov, A. A. Kholin, U. A. Kukota, N. A. Medvedeva, A. S. Shapovalov, A. E. Druy
Publikováno v:
Русский журнал детской неврологии, Vol 19, Iss 2, Pp 64-71 (2024)
Diffuse leptomeningeal glioneuronal tumor was introduced into the World Health Organization classification of central nervous system tumors in 2016. According to the actual World Health Organization classification of central nervous system tumors eme
Externí odkaz:
https://doaj.org/article/dfea64631e4c4f06ae2c35b96c178dfb
Publikováno v:
Zhongguo aizheng zazhi, Vol 34, Iss 7, Pp 695-701 (2024)
Leptomeningeal metastasis (LM) is a serious late complication in patients with solid tumors, which is common in patients with lung cancer, breast cancer and melanoma. In recent years, due to the progress of diagnosis, the diagnosis rate of LM has gra
Externí odkaz:
https://doaj.org/article/cd3e98ad6d3c446d96ff639de09a9ee3
Autor:
Niraula, Sujan 1, Gouli, Sugam 2, Baran, AndreaM. 3, O'Regan, Ruth 3, Tyburski, Haley 3, Zhang, Huina 3, Hardy, Sara 4, Mohile, Nimish 3, Anders, Carey K. 5, Dhakal, Ajay 3, ⁎
Publikováno v:
In Clinical Breast Cancer January 2025 25(1):65-74